Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1158031212 | 11580312 | 12 | F | 2016 | 20160804 | 20150930 | 20160811 | EXP | PHHY2015CA115923 | SANDOZ | 0.00 | F | Y | 0.00000 | 20160811 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1158031212 | 11580312 | 1 | SS | NEORAL | CYCLOSPORINE | 1 | Oral | 4 MG/KG, QD | Y | 0 | 4 | MG/KG | QD | ||||||
| 1158031212 | 11580312 | 2 | PS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 20 MG, QW | Y | 90029 | 20 | MG | CAPSULE | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 1158031212 | 11580312 | 1 | Psoriasis |
| 1158031212 | 11580312 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 1158031212 | 11580312 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 1158031212 | 11580312 | Chronic hepatitis | |
| 1158031212 | 11580312 | Cystitis | |
| 1158031212 | 11580312 | Drug ineffective | |
| 1158031212 | 11580312 | Herpes zoster | |
| 1158031212 | 11580312 | Nephropathy | |
| 1158031212 | 11580312 | Ophthalmic herpes zoster | |
| 1158031212 | 11580312 | Psoriasis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |